| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/13/2014 | US8722625 Treatment of cardiovascular disorders using the cell differentiation signaling protein Nell1 |
| 05/13/2014 | US8722617 Mussel adhesive protein derived vectors for gene delivery |
| 05/13/2014 | US8722051 Tweak receptor |
| 05/13/2014 | US8722034 hUTC as therapy for Alzheimer's disease |
| 05/13/2014 | CA2584681C Pearmease and suicide genes for antitumoral or antiviral treatment |
| 05/13/2014 | CA2514058C Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer |
| 05/13/2014 | CA2505394C Human stem cell materials and methods |
| 05/13/2014 | CA2479042C Cartilage regeneration using chondrocyte and tgf-.beta. |
| 05/13/2014 | CA2471035C Knockout swine and methods for making the same |
| 05/13/2014 | CA2404253C Novel ecdysone receptor-based inducible gene expression system |
| 05/13/2014 | CA2270345C Immunostimulatory nucleic acid molecules |
| 05/08/2014 | WO2014071323A2 Inhibition of histone methyltransferase for cardiac reprogramming |
| 05/08/2014 | WO2014071316A1 In silico identification of cancer molecular signaling pathways and drug candidates |
| 05/08/2014 | WO2014071275A1 Compositions and methods for auditory therapy |
| 05/08/2014 | WO2014071219A1 Methods and products for expressing proteins in cells |
| 05/08/2014 | WO2014070687A2 Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells |
| 05/08/2014 | WO2014070111A1 A novel reagent for gene-drug therapeutics |
| 05/08/2014 | WO2014068568A1 Light-sensitive ion channels for induction of cardiac activity |
| 05/08/2014 | WO2014068566A1 Light-sensitive pumps for suppression of cardiac activity |
| 05/08/2014 | WO2014068063A1 A rna trans-splicing molecule (rtm) for use in the treatment of cancer |
| 05/08/2014 | WO2013055420A3 Novel clostridium difficile dna vaccine |
| 05/08/2014 | WO2013032962A3 Micro rnas to treat stroke, ischemic brain injury, traumatic brain injury, and neurodegenerative disease |
| 05/08/2014 | US20140128316 Integrase cofactor |
| 05/08/2014 | US20140127751 Wise/sost nucleic acid sequences and amino acid sequences |
| 05/08/2014 | US20140127250 Staphylococcus aureus proteins and nucleic acids |
| 05/08/2014 | US20140127162 Reversible gene expression |
| 05/07/2014 | EP2728005A1 Lrp1 as key receptor for the transfer of sterified cholesterol from very-low-density lipoproteins (vldl) to ischaemic cardiac muscle |
| 05/07/2014 | EP2727600A1 Methods and compositions for treating trinucleotide repeat disorders |
| 05/07/2014 | EP2726498A1 Photoactivatable receptors and their uses |
| 05/07/2014 | EP2726109A2 Compositions and methods for treating skeletal myopathy |
| 05/07/2014 | EP2726108A2 Inhibitor of neuronal connectivity linked to schizophrenia susceptibility and cognitive dysfunction |
| 05/07/2014 | CN103781906A 抑制细胞生长的方法、对nek10变异基因具有rna干扰效应的核酸分子、以及抗癌剂 Method of inhibiting cell growth, for nek10 mutant gene has a nucleic acid molecule rna interference effects, as well as anti-cancer agents |
| 05/07/2014 | CN103781475A 利用纳米胶囊口服递送酶以实现酒精或有毒代谢物的靶向代谢 Use of nano-capsules for oral delivery of enzyme to achieve or toxic metabolite of alcohol metabolism targeting |
| 05/07/2014 | CN103773802A Hip-55蛋白在开发抑制肿瘤药物中的应用 Hip-55 protein in the development of a medicament for inhibiting tumor Application |
| 05/07/2014 | CN103773771A 一种转录因子组及其制备方法、应用 A transcription factor group and its preparation method and application |
| 05/07/2014 | CN103773768A 一种干扰HIP-55的siRNA及其在抗肿瘤中的应用 An interference HIP-55 of siRNA and its application in anti-tumor |
| 05/07/2014 | CN103773767A 靶向adgb的抑制性rna及其在制备抗肿瘤药物中的应用 Targeting adgb inhibitory rna and its application in the preparation of antineoplastic |
| 05/07/2014 | CN103773764A 一种miRNA及在制备后发性白内障诊疗制品中的应用 One miRNA and its application in the manufacture of products after cataract clinics in |
| 05/07/2014 | CN103773743A 一种重组恒河猴尿酸酶蛋白及其应用 A recombinant uricase protein and its application rhesus |
| 05/07/2014 | CN103772508A 免疫增强的人乳头瘤病毒感染及相关疾病的治疗性疫苗 Immune enhancement of human papillomavirus infection and therapeutic vaccine-related diseases |
| 05/07/2014 | CN103772504A 人源化抗表皮生长因子受体抗体及其用途 The humanized anti-epidermal growth factor receptor antibodies, and uses |
| 05/07/2014 | CN103769018A 改性凝集素包裹的磁性大分子脂质体纳米微球、制备方法及应用 Modified lectin coated magnetic nanoparticles macromolecular liposomes, preparation method and application |
| 05/07/2014 | CN103768617A 纳米金miR-375偶联物及其制备方法和应用 Nano Gold miR-375 conjugate and its preparation method and application |
| 05/07/2014 | CN103768601A 抑制micro-RNA155用于预防和治疗动脉粥样硬化的方法 Method of inhibiting micro-RNA155 for the prevention and treatment of atherosclerosis |
| 05/07/2014 | CN103013997B 抑制透明质酸酶活性的miRNA及其应用 MiRNA inhibition of hyaluronidase activity and its application |
| 05/07/2014 | CN102899343B 一种基因载体系统及其制备和应用 Of a gene vector system and its preparation and application |
| 05/07/2014 | CN102827875B 表达小鼠神经生长因子的重组腺病毒及其制备方法 Expression of mouse nerve growth factor recombinant adenovirus and its preparation method |
| 05/07/2014 | CN102766630B 6-修饰的双环核酸类似物 6- modified bicyclic nucleic acid analogs |
| 05/07/2014 | CN102719443B 一种羧基末端特异的抗人淀粉样蛋白单克隆抗体基因和其编码多肽及应用 One kind of the carboxyl-terminal human-specific anti-amyloid monoclonal antibody genes and their encoded polypeptides and Applications |
| 05/07/2014 | CN102604938B 可用于诱导肝细胞损伤的rna干扰靶点 Can be used to induce liver cell injury rna interference target |
| 05/07/2014 | CN102292092B 致敏细胞疗法 Sensitized cell therapy |
| 05/07/2014 | CN102099471B 针对il-17的适配体及其用途 For il-17 and its use of aptamers |
| 05/07/2014 | CN102008441B Endoglin抗体偶联的脂质体及其制备方法和应用 Liposomes and its preparation method and application Endoglin antibody conjugated |
| 05/07/2014 | CN101583381B Hsv-1和hsv-2疫苗和其使用方法 Hsv-1 hsv-2 vaccines and their use and |
| 05/06/2014 | US8716462 Levels and/or sustainability of DNA-based gene expression |
| 05/06/2014 | US8716460 Pseudomonas AVR and HOP proteins, their encoding nucleic acids, and use thereof |
| 05/06/2014 | US8716455 Genetic products differentially expressed in tumors and use thereof |
| 05/06/2014 | US8716301 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation |
| 05/06/2014 | US8716258 Regulation of metabolism by miR-378 |
| 05/06/2014 | US8716245 Tissue protective peptides and uses thereof |
| 05/06/2014 | US8716232 Use of endostatin peptides for the treatment of fibrosis |
| 05/06/2014 | US8716217 Polyglutamic acids functionalized by cationic groups and hydrophobic groups and applications thereof, in particular therapeutic applications thereof |
| 05/06/2014 | US8716013 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
| 05/06/2014 | US8715968 Methods and reagents for modulating cholesterol levels |
| 05/06/2014 | US8715940 Method of making recombinant influenza virus |
| 05/06/2014 | US8715922 Virus causing respiratory tract illness in susceptible mammals |
| 05/06/2014 | US8715742 Method for reducing weight in a subject |
| 05/06/2014 | US8715690 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 05/06/2014 | US8715689 Chimeric west nile/dengue viruses |
| 05/06/2014 | US8715667 Methods of treating patients having TLR3-positive cancer |
| 05/06/2014 | US8715645 Viral vectors encoding apoptosis-inducing proteins and methods for making and using the same |
| 05/06/2014 | US8715620 Treatment of asthma in mammals with clostridia neurotoxins |
| 05/06/2014 | CA2655355C Use of rpn2 gene expression inhibitor |
| 05/06/2014 | CA2527756C Immunostimulating agents |
| 05/06/2014 | CA2488059C Non-polymeric hematopoietic cell clots for delivery of active agents |
| 05/06/2014 | CA2459202C Adipose-derived stem cells and lattices |
| 05/06/2014 | CA2401327C Nucleic acid formulations comprising poly-amino acids for gene delivery and methods of use |
| 05/01/2014 | WO2014066915A2 Methods and compositions to produce ss-rnai activity with enhanced potency |
| 05/01/2014 | WO2014066898A1 A layer-by-layer approach to co-deliver dna and sirna via aunps: a potential platform for modifying release kinetics |
| 05/01/2014 | WO2014066830A1 Composition and methods for the prevention and treatment of diet-induced obesity |
| 05/01/2014 | WO2014066084A1 Nucleic acid modulators of alpha2beta1 |
| 05/01/2014 | WO2014065606A1 Agent for treating nerve disease, comprising osmotin composition and inhibitor for inhibiting expression or activity of gaba b receptor proteins |
| 05/01/2014 | WO2014065210A1 Vaccine for preventing porcine edema disease |
| 05/01/2014 | WO2014064687A1 A system for delivering therapeutic agents into living cells and cells nuclei |
| 05/01/2014 | WO2014064277A1 Vector for liver-directed gene therapy of hemophilia and methods and use thereof |
| 05/01/2014 | WO2014063753A1 Hyper-active factor ix vectors for liver-directed gene therapy of hemophilia 'b' and methods and use thereof |
| 05/01/2014 | WO2014063602A1 New drug targeting delivery adjuvant |
| 05/01/2014 | WO2014018295A4 Therapeutic anti-virus vlps |
| 05/01/2014 | WO2014008263A3 Paramyxovirus and methods of use |
| 05/01/2014 | WO2013025834A9 Compositions and methods related to antibodies to staphylococcal protein a |
| 05/01/2014 | WO2012135246A3 Compositions and methods for inhibiting expression of tmprss6 gene |
| 05/01/2014 | US20140121365 Oligomeric compounds and compositions for use in modulation of small non-coding rnas |
| 05/01/2014 | US20140121364 Oligomeric compounds and compositions for use in modulation of small non-coding rnas |
| 05/01/2014 | US20140121160 Use of VEGF in the Treatment of Retarded Fetal Growth in Pregnancy |
| 05/01/2014 | US20140121115 Custom-made meganuclease and use thereof |
| 05/01/2014 | US20140120089 Antibodies to insulin-like growth factor i receptor |
| 05/01/2014 | US20140120085 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy |
| 04/30/2014 | EP2725101A1 Protein comprising truncated form of extracellular domain protein of frizzled 2, and pharmaceutical composition for treating bone diseases which comprises said protein |
| 04/30/2014 | EP2724729A1 Apoptosis-inducing agent |
| 04/30/2014 | EP2723391A2 Fibroblast growth factor receptor inhibition for the treatment of disease |